Takuji Kurimoto Selected Research

Takuji Kurimoto Research Topics

Disease

7	Glaucoma 11/2022 - 01/2010
5	Inflammation (Inflammations) 11/2021 - 11/2010
5	Optic Nerve Injuries 12/2020 - 05/2008
5	Optic Neuritis (Retrobulbar Neuritis) 01/2020 - 01/2011
4	Ganglion Cysts (Ganglion) 01/2020 - 07/2008
3	Cataract (Cataracts) 09/2022 - 01/2020
3	Neuromyelitis Optica (Devic's Disease) 01/2020 - 01/2017
2	Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy) 01/2020 - 01/2019
2	Paralysis (Palsy) 09/2019 - 03/2013
2	Gliosis 06/2012 - 03/2010
1	Diabetes Mellitus 09/2022
1	Sphenoid Sinusitis 01/2021
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 09/2020
1	Neurosarcoidosis 09/2020
1	Nausea 01/2020
1	Residual Neoplasm 09/2019
1	Thrombosis (Thrombus) 12/2018
1	Neoplasms (Cancer) 05/2018
1	Hypothyroidism 05/2018
1	Hypopituitarism (Sheehan's Syndrome) 05/2018
1	Lymphoma (Lymphomas) 05/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2018
1	Scotoma (Scintillating Scotoma) 05/2018
1	Macular Degeneration (Age-Related Maculopathy) 01/2018
1	Neuroinflammatory Diseases 06/2012
1	Sinusitis 01/2011
1	Retinal Artery Occlusion 01/2011
1	Anisocoria 01/2011
1	Ophthalmoplegia (External Ophthalmoplegia) 01/2011
1	Fever (Fevers) 01/2011
1	Headache (Headaches) 01/2011
1	Meningoencephalitis 01/2011
1	Retinal Diseases 12/2010
1	Wounds and Injuries (Trauma) 03/2010
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2010
1	Atherosclerosis 01/2010
1	Cerebral Infarction 05/2008

Drug/Important Bio-Agent (IBA)

5	Retinaldehyde (Retinal)IBA 01/2020 - 07/2008
5	SteroidsIBA 09/2019 - 01/2011
3	Pharmaceutical PreparationsIBA 09/2022 - 11/2021
3	Ophthalmic Solutions (Eye Drops)IBA 12/2021 - 01/2010
3	Prednisolone (Predate)FDA LinkGeneric 01/2020 - 01/2011
2	AnticoagulantsIBA 11/2022 - 12/2018
2	Antiviral Agents (Antivirals)IBA 11/2021 - 01/2011
2	TESIBA 01/2011 - 12/2010
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2010 - 05/2008
1	Dimethyl FumarateIBA 12/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2020
1	Mitochondrial DNA (mtDNA)IBA 01/2020
1	EnzymesIBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	Laminin (Merosin)IBA 01/2020
1	Aquaporin 4IBA 01/2020
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2020
1	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	GadoliniumIBA 12/2018
1	B7-H1 AntigenIBA 05/2018
1	cyclopropapyrroloindoleIBA 05/2018
1	Hydrocortisone (Cortisol)FDA LinkGeneric 05/2018
1	Hormones (Hormone)IBA 05/2018
1	Adrenocorticotropic Hormone (ACTH)FDA Link 05/2018
1	AutoantibodiesIBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 09/2013
1	Ciliary Neurotrophic Factor (CNTF)IBA 09/2013
1	Leukemia Inhibitory FactorIBA 09/2013
1	Immunoglobulins (Immunoglobulin)IBA 01/2013
1	Endothelins (Endothelin)IBA 06/2012
1	Endothelin B ReceptorIBA 06/2012
1	Vidarabine (Vira-A)FDA Link 01/2011
1	Betamethasone (Celestone)FDA Link 01/2011
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2010
1	Mitogen-Activated Protein KinasesIBA 11/2010
1	ZymosanIBA 11/2010
1	oncomodulinIBA 11/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2010
1	bcl-X ProteinIBA 03/2010
1	Glial Fibrillary Acidic ProteinIBA 03/2010
1	SuspensionsIBA 01/2010
1	Cyclic AMP (AMP, Cyclic)IBA 01/2010
1	Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA 07/2009
1	Endothelin-1 (Endothelin 1)IBA 07/2008
1	Nerve Growth Factors (Neurotrophins)IBA 05/2008
1	Neuroprotective AgentsIBA 05/2008
1	Cilostazol (Pletal)FDA LinkGeneric 05/2008
1	Cyclic NucleotidesIBA 05/2008

Therapy/Procedure

6	Therapeutics 11/2021 - 01/2011
3	Trabeculectomy (Trabeculoplasty) 11/2022 - 01/2018
1	Filtering Surgery 11/2021
1	Debridement 01/2021
1	Blood Component Removal (Apheresis) 07/2018
1	Intravitreal Injections 05/2008